AHEAD score — Long-term risk classification in acute heart failure
Jindřich Špinar(Masaryk University), Jiří Pařenica(Masaryk University), Marián Felšőci(Masaryk University), K Zeman, Jiří Kettner(Institute of Clinical and Experimental Medicine), Simona Littnerová(Masaryk University), Jiří Jarkovský(Masaryk University), Roman Miklík(Masaryk University), Jan Bělohlávek(Charles University), Lenka Špinarová(Masaryk University), Étienne Gayat(Inserm), Petr Ošťádal(Charles University), J. Václavík, Aleš Linhart(Charles University), Filip Málek(Na Homolce Hospital), Alexandre Mebazaa(Délégation Paris 5), C Cíhalík(University Hospital Olomouc), Miloš Táborský(University of Belgrade), Ladislav Dušek(Fondazione IRCCS Istituto Nazionale dei Tumori), Jiří Vítovec(Sahlgrenska University Hospital), Petr Widimský(Charles University)
Cited by 94
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k